Position in MRK
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$3,020,521
+$159,424 QoQ
Shares Held
23,506
-1.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.38%
of 13F equity value
Holder Rank
#1,340
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Checchi Capital Advisers, LLC holds $38,252,347 across 13 Drug Manufacturers - General names. MRK ranks #4 (7.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
10,032 | $12,032,682 | |
| 2 | JNJ |
Johnson & Johnson
|
28,318 | $7,191,922 | |
| 3 | ABBV |
AbbVie Inc.
|
19,940 | $5,017,701 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
23,506 | $3,020,521 | |
| 5 | NVS |
Novartis AG
|
16,953 | $2,656,874 | |
| 6 | AMGN |
Amgen Inc
|
6,176 | $2,236,453 | |
| 7 | AZN |
Astrazeneca PLC
|
9,648 | $1,829,453 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
9,839 | $1,243,059 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,020,521 | 23,506 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $2,861,097 | 23,785 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $2,372,560 | 22,540 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $1,936,936 | 23,078 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $2,040,428 | 25,776 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $2,486,082 | 27,697 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $2,762,758 | 27,772 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $3,194,556 | 28,131 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $3,677,850 | 29,708 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $3,817,181 | 28,929 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $3,123,423 | 28,650 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $3,026,627 | 29,399 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $3,571,551 | 30,952 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $3,292,025 | 30,943 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $3,327,834 | 29,994 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $2,677,384 | 31,089 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $2,778,770 | 30,479 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $2,239,390 | 27,293 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $1,983,903 | 25,886 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $1,992,818 | 26,532 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $2,188,525 | 28,141 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $2,231,525 | 28,947 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $2,340,215 | 28,609 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $2,369,965 | 28,571 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $2,189,754 | 28,317 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $2,185,325 | 28,403 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||